tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Benjamin Burnett, 233 are a BUY (72.36%), 89 are a HOLD (27.64%).
Analyst Benjamin Burnett, currently employed at WELLS FARGO, carries an average stock price target met ratio of 43.87% that have a potential upside of 33.54% achieved within 111 days.
Benjamin Burnett’s has documented 632 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on LQDA, Liquidia Technologies at 14-Oct-2026.
Analyst best performing recommendations are on EFTR (EFFECTOR THERAPEUTICS).
The best stock recommendation documented was for CRSP (CRISPR THERAPEUTICS AG) at 2/13/2025. The price target of $49 was fulfilled within 1 day with a profit of $5.51 (12.67%) receiving and performance score of 126.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Aug-2026
$6
$4.69 (358.02%)
$5
2 months 5 days ago
(17-Aug-2026)
1/10 (10%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.5 (566.67%)
$10
6 months ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Buy Since 04-Apr-2023
$11
$8.87 (416.43%)
$12
6 months 6 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Sell Since 16-Apr-2026
6 months 6 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Hold Since 21-Mar-2023
$3.85
$1.72 (80.75%)
$2.5
6 months 8 days ago
(14-Apr-2026)
2/3 (66.67%)
$1.13 (41.54%)
155
Which stock is Benjamin Burnett most bullish on?
Which stock is Benjamin Burnett most reserved on?
What Year was the first public recommendation made by Benjamin Burnett?
